Acacia
Biosciences, Inc. is a drug discovery technology company committed to the creation of
proprietary assay systems and databases that facilitate the rapid development of
biopharmaceutical s
and agricultural chemicals. The Genome Reporter Matrix is the first in a series of novel
tools that
provide practical analysis of early stage chemicals by interpreting their effects across
entire genomes.
In addition to the GRM, Acacia's technology is used to discover novel targets and gene
regulatory
mechanisms. |
